MAXX
Dead / Abandoned — Abandoned — failure to respond (as of 05 Mar 2021)
What this means for you
This application is over — abandoned 23 Feb 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86858763
- Mark type
- Stylized text
- Filed
- 28 Dec 2015
- Published for opposition
- 14 Jun 2016
- Abandoned
- 23 Feb 2021
- Attorney of record
- David Meibos
Goods and services
- Class 010 — Medical apparatus: Autologous biomaterial collection, processing, and therapeutic application systems comprised of medical instruments and equipment for the collection, processing and therapeutic application of bone marrow for use in platelet rich plasma therapy for orthopedic, aesthetic and cosmetic purposes only and limited to in-office and operating room use
Owner
- Royal Biologics, Inc., Hackensack, NJ, US
- Royal Biologics, Inc., Long Island City, NY, US
Prosecution history
- 05 Mar 2021 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 05 Mar 2021 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 21 Aug 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 21 Aug 2020 — NON-FINAL ACTION E-MAILED
- 21 Aug 2020 — SU - NON-FINAL ACTION - WRITTEN
- 04 Aug 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 30 Jul 2020 — USE AMENDMENT FILED
- 30 Jul 2020 — TEAS STATEMENT OF USE RECEIVED
- 15 Jan 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Jan 2020 — SOU EXTENSION 5 GRANTED
- 09 Jan 2020 — SOU EXTENSION 5 FILED
- 14 Jan 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 09 Jan 2020 — SOU TEAS EXTENSION RECEIVED
- 22 May 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 May 2019 — SOU EXTENSION 4 GRANTED